Afya
AFYA
Market cap $1.63B

18.04 USD

+0.11

0.61%

Updated Apr 1, 2:48 PM EDT

1 day

0.61%

5 days

1.06%

1 month

9.67%

3 months

15.42%

6 months

4.34%

Year to date

15.42%

1 year

-2.64%

5 years

0.50%

10 years

-25.11%

About: Afya Ltd is a medical education group based in Brazil. Its education portfolio has several courses in addition to Medicine, such as Management, Dentistry, Law, Engineering, Nursing, Psychology, and Accounting Sciences, among others. It has three segments; Undergrad provides educational services through undergraduate courses related to medicine, other health sciences, and other undergraduate programs, Continuing Education provides specialization programs and graduate courses in medicine; and Digital Services provides content and technology for medical education, clinical decisions software, practice management tools (that encompass electronic medical records, telemedicine, and digital prescription, and provides access, demand and efficiency for the healthcare players.

Employees: 10,181

Consumer Discretionary Educational Services

0

Funds holding %

of 7,398 funds

0

Analysts bullish %

of 3 analysts

Fund manager confidence

Based on 2024 Q4 regulatory filings by fund managers ($100M+ AUM)

293% more call options, than puts

Call options by funds: $59K | Put options by funds: $15K

28% more capital invested

Capital invested by funds: $190M [Q3] → $242M (+$52.5M) [Q4]

8.92% more ownership

Funds ownership: 23.99% [Q3] → 32.91% (+8.92%) [Q4]

0% more funds holding in top 10

Funds holding in top 10: 1 [Q3] → 1 (+0) [Q4]

4% less repeat investments, than reductions

Existing positions increased: 24 | Existing positions reduced: 25

16% less funds holding

Funds holding: 74 [Q3] → 62 (-12) [Q4]

58% less first-time investments, than exits

New positions opened: 8 | Existing positions closed: 19

See Fund Rankings

Research analyst outlook

3 Wall Street Analysts provided 1 year price targets over the past 3 months

Low target

$15

17%

downside

Avg. target

$17.50

3%

downside

High target

$21

14%

upside

3 analyst ratings

0 positive

0%

1 neutral

33%

2 negative

67%

Morgan Stanley Mauricio Cepeda 0% 1-year accuracy 0 / 3 met price target	6%downside $17	Underweight Downgraded	11 Mar 2025
Citigroup Leandro Bastos 0% 1-year accuracy 0 / 2 met price target	17%downside $15	Sell Downgraded	31 Jan 2025
JP Morgan Marcelo Santos 67% 1-year accuracy 4 / 6 met price target	14%upside $21	Neutral Maintained	17 Jan 2025

See Analyst Rankings

Financial journalist opinion

Based on 3 articles about AFYA published over the past 30 days

Zacks Investment Research

Afya (AFYA) Surpasses Q4 Earnings and Revenue Estimates

Afya (AFYA) came out with quarterly earnings of $0.36 per share, beating the Zacks Consensus Estimate of $0.34 per share. This compares to earnings of $0.36 per share a year ago.

Afya (AFYA) Surpasses Q4 Earnings and Revenue Estimates

Afya Limited Announces Fourth Quarter and Full-Year 2024 Financial Results

NOVA LIMA, Brazil--(BUSINESS WIRE)--Afya Limited (Nasdaq: AFYA; B3: A2FY34) (“Afya” or the “Company”), the leading medical education group and medical practice solutions provider in Brazil, reported today its financial and operating results for the fourth quarter and full-year period ended December 31, 2024. Financial results are expressed in Brazilian Reais and are presented in accordance with International Financial Reporting Standards (IFRS). Fourth Quarter 2024 Highlights 4Q24 Net Revenue i.

Afya Limited Announces Fourth Quarter and Full-Year 2024 Financial Results

Afya Limited Announces First Dividend Distribution of R$129.8 Million

NOVA LIMA, Brazil--(BUSINESS WIRE)--Afya Limited (Nasdaq: AFYA; B3: A2FY34) ("Afya" or the "Company"), Brazil's leading medical education group and provider of medical practice solutions, announced that its board of directors (the “Board”) approved its first distribution of a cash dividend. On March 12, 2025, Afya's Board declared a cash dividend of R$129.8 million, representing 20% of the Company's consolidated net income of R$648.9 million for the year ended December 31, 2024. This amounts to.

Afya Limited Announces First Dividend Distribution of R$129.8 Million

Zacks Investment Research

Afya to Expand Medical Education Reach With FUNIC Acquisition

AFYA has announced a share purchase agreement to acquire 100% of FUNIC.

Afya to Expand Medical Education Reach With FUNIC Acquisition

Afya Limited Announces Entering Into a Share Purchase Agreement for the Acquisition of Faculdade Única de Contagem

NOVA LIMA, Brazil--(BUSINESS WIRE)--Afya Limited (Nasdaq: AFYA; B3: A2FY34) (“Afya” or the “Company”), the leading medical education group and medical practice solutions provider in Brazil, announced today that it has entered into a share purchase agreement for the acquisition, through its wholly-owned subsidiary Afya Participações S.A., of 100% of the total share capital of Faculdade Masterclass Ltda. (“Faculdade Única de Contagem” or “FUNIC”), present in Contagem (MG). The acquisition will ad.

Afya Limited Announces Entering Into a Share Purchase Agreement for the Acquisition of Faculdade Única de Contagem

Afya Continues To Be An Opportunity Even After Brazil's Depreciation

Afya's 3Q24 results showed 12% organic revenue growth and 16% overall growth, driven by the Unidom acquisition and strong performance in medical education and software segments. The company leveraged its cost structure, achieving a 300bps increase in adj EBITDA margin and a 68% YoY net income growth despite higher financial costs. Afya's valuation remains attractive, with a P/E of 11x and a potential yield of 20% in a few years, justifying a Buy rating.

Afya Continues To Be An Opportunity Even After Brazil's Depreciation

Zacks Investment Research

Afya (AFYA) Q3 Earnings Miss Estimates

Afya (AFYA) came out with quarterly earnings of $0.32 per share, missing the Zacks Consensus Estimate of $0.36 per share. This compares to earnings of $0.28 per share a year ago.

Afya (AFYA) Q3 Earnings Miss Estimates

Afya Limited Third Quarter and Nine Months 2024 Financial Results

NOVA LIMA, Brazil--(BUSINESS WIRE)--Afya Limited (Nasdaq: AFYA; B3: A2FY34) (“Afya” or the “Company”), the leading medical education group and medical practice solutions provider in Brazil, reported today financial and operating results for the three and nine-month periods ended September 30, 2024 (third quarter 2024). Financial results are expressed in Brazilian Reais and are presented in accordance with International Financial Reporting Standards (IFRS). Third Quarter 2024 Highlights 3Q24 Net.

Afya Limited Third Quarter and Nine Months 2024 Financial Results

Afya Limited to Report Third Quarter and Nine Months 2024 Financial Results on November 13th

NOVA LIMA, Brazil--(BUSINESS WIRE)--Afya Limited (Nasdaq: AFYA; B3: A2FY34) (“Afya” or the “Company”), the leading medical education group and medical practice solutions provider in Brazil, announced today that it will report third-quarter and nine months 2024 financial results for the period ended September 30th, 2024, following the close of the market on Wednesday, November 13th, 2024 and will host a corresponding conference call and webcast at 05:00 pm EST. A live and archived webcast of the.

Afya Limited to Report Third Quarter and Nine Months 2024 Financial Results on November 13th

Zacks Investment Research

Is the Options Market Predicting a Spike in AFYA Stock?

Investors need to pay close attention to AFYA stock based on the movements in the options market lately.

Is the Options Market Predicting a Spike in AFYA Stock?

See News Rankings

Charts implemented using Lightweight Charts™